Lord, Abbett & Co’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $25.5M | Sell |
|
|||||
|
2024
Q4 | $29.2M | Sell |
|
|||||
|
2024
Q3 | $109M | Sell |
|
|||||
|
2024
Q2 | $128M | Sell |
|
|||||
|
2024
Q1 | $125M | Sell |
|
|||||
|
2023
Q4 | $134M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $60.2M | Buy |
|
|||||
|
2021
Q3 | $43.7M | Sell |
|
|||||
|
2021
Q2 | $38.5M | Sell |
|
|||||
|
2021
Q1 | $46.9M | Sell |
|
|||||
|
2020
Q4 | $65.8M | Buy |
|
|||||
|
2020
Q3 | $38.7M | Buy |
|
|||||
|
2020
Q2 | $24.2M | Buy |
|
|||||
|
2020
Q1 | $17.4M | Sell |
|
|||||
|
2019
Q4 | $42.5M | Sell |
|
|||||
|
2019
Q3 | $73.9M | Buy |
|
|||||
|
2019
Q2 | $92.1M | Buy |
|
|||||
|
2019
Q1 | $66.5M | Buy |
|
|||||
|
2018
Q4 | $28.9M | Buy |
|
|||||
|
2018
Q3 | $32.1M | Sell |
|
|||||
|
2018
Q2 | $52.4M | Sell |
|
|||||
|
2018
Q1 | $146M | Sell |
|
|||||
|
2017
Q4 | $134M | Buy |
|
|||||
|
2017
Q3 | $123M | Buy |
|
|||||
|
2017
Q2 | $87.6M | Buy |
|
|||||
|
2017
Q1 | $68.8M | Buy |
|
|||||
|
2016
Q4 | $30.3M | Buy |
|
|||||
|
2016
Q3 | $8.38M | Buy |
|
|||||
|
2016
Q2 | $4.26M | Buy |
|
|||||
|
2016
Q1 | $2.29M | Sell |
|
|||||
|
2015
Q4 | $19.8M | Buy |
|
|||||
|
2015
Q3 | $13.7M | Sell |
|
|||||
|
2015
Q2 | $19.5M | Buy |
|